ANGO — ANGIODYNAMICS INC

Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 1275187 ·
Last close
$11.80
Market Cap
$487.56M
52W High
$12.20
52W Low
$9.39
ADV30
342,053
Next earnings
AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall endothelium. The company's thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit for use in extracorporeal circulatory support procedures for periods of up to six hours, as well as with other manufacturers' off-the-shelf pump, filter, and reinfusion cannula facilitate venous drainage. It also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, diagnostic and interventional guidewires, and coaxial micro-introducer kits for use in peripheral diagnostic and interventional procedures. In addition, the company provides abscession drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-access kits offer interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero Microwave Tissue Ablation System includes solero microwave generator and the solero MW applicators. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Feb 2026 78,423,000 41,479,000 -6,429,000 -8,084,000 260,678,000 37,810,000 87,321,000
Nov 2025 79,433,000 44,783,000 -2,490,000 -6,350,000 269,681,000 41,638,000 93,348,000
Aug 2025 75,711,000 41,857,000 -7,898,000 -10,903,000 265,642,000 38,762,000 86,787,000
May 2025 80,158,000 42,218,000 -3,633,000 -6,050,000 280,144,000 55,893,000 97,174,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$4,448,000
Investing CF
$-7,302,000
Financing CF
$-5,098,000
CapEx
$-2,945,000
Dividends Paid
Buybacks
$0
EPS Diluted TTM
$-0.71
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$-454,534,000
Inventory
$58,578,000
Receivables
$45,552,000
ST Investments
EBIT TTM
$-20,450,000
Pretax Income TTM
$-31,375,000
Interest Exp TTM
Analysts
4

Yahoo Snapshot (yfinance, live)

Total Revenue
$313,724,992
EBITDA
$-659,000
Free Cash Flow
$13,942,250
Enterprise Value
$470,434,592
Total Cash
$37,810,000
Total Debt
$11,394,000
Shares Out
41,318,915
Trailing EPS
$-0.76
Book Value
$4.16
ROE
-17.5%
ROA
-4.7%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
May 2025 292,498,000 -24,062,000 -33,993,000 280,144,000 97,174,000 -10,128,000
May 2024 303,914,000 -33,844,000 -184,349,000 317,671,000 112,085,000 -28,158,000
May 2023 338,752,000 -18,679,000 -52,442,000 532,637,000 154,341,000 78,000
May 2022 316,219,000 -18,217,000 -26,547,000 552,751,000 128,262,000 -7,194,000

TTM Snapshot

Revenues TTM
$297,489,000
NetIncome TTM
$-210,369,000
OpCashFlow TTM
$0
Assets (Latest)
$280,144,000
Forward EPS
$-0.22

Peers — same industry

TickerNameMarket CapLastDaily %
KIDS ORTHOPEDIATRICS CORP $459.76M $17.90
BBNX Beta Bionics, Inc. $522.26M $11.72
MDXG MIMEDX GROUP, INC. $546.63M $3.67
CERS CERUS CORP $547.01M $2.73
TCMD TACTILE SYSTEMS TECHNOLOGY INC $565.26M $25.06

News headlines (Yahoo Finance, 1h cache)

Wall Street Analysts See a 50.5% Upside in AngioDynamics (ANGO): Can the Stock Really Move This High?
2026-05-22 13:55 · Yahoo
Reasons to Add AngioDynamics Stock to Your Portfolio for Now
2026-05-19 15:47 · Yahoo
AngioDynamics Announces Two-Year PRESERVE Trial Data Demonstrating Durable NanoKnife IRE System Outcomes in Intermediate-Risk Prostate Cancer
2026-05-13 13:00 · Yahoo
Wall Street Analysts Think AngioDynamics (ANGO) Could Surge 64.23%: Read This Before Placing a Bet
2026-05-06 13:55 · Yahoo
Wall Street Analysts Believe AngioDynamics (ANGO) Could Rally 65.75%: Here's is How to Trade
2026-04-20 13:55 · Yahoo
AngioDynamics CEO Touts Debt-Free Turnaround, Auryon Share Gains, NanoKnife Launch at Needham Conf
2026-04-15 01:03 · Yahoo
AngioDynamics (ANGO) Loses 5.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
2026-04-10 13:35 · Yahoo
AngioDynamics (ANGO) Upgraded to Buy: Here's Why
2026-04-08 16:00 · Yahoo
ANGO Stock Up in Pre-Market Post Q3 Earnings Beat, Gross Margin Down
2026-04-06 16:12 · Yahoo
AngioDynamics Inc (ANGO) Q3 2026 Earnings Call Highlights: Strong Revenue Growth Amid Financial ...
2026-04-02 19:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.